Wipro Partners with Pandorum Technologies to Accelerate Regenerative Medicine with AI


The global IT and consulting company announced a long-term partnership with Pandorum Technologies, a biotechnology company working in the field of tissue engineering and regenerative medicine.

Together, the companies will focus on developing technologies that shorten time to market and maximize patient outcomes during regenerative medicine R&D and clinical trials. The partnership combines Wipro Holmes’ artificial intelligence (AI) capabilities with Pandorum’s expertise in regenerative medicine.



The initial focus of the collaboration will be “bio-engineered liquid cornea” and will extend to the entire product portfolio, including regenerative lung and liver tissue. Wipro Holmes’ AI-based decision support solution will provide insight into the potential outcomes of specific formulations, apply advanced algorithms to predict and improve treatment efficacy, and aid in the design of clinical studies.

On a consolidated basis, Wipro recorded a 1.3% increase in net profit to Rs 2,970 crore on a 3.3% increase in operating income to Rs 20,313.6 crore in Q3 FY22 compared to Q2 FY22. On a yearly basis, Wipro’s net profit fell 0.85% while revenue grew 29.63% in Q3 FY22.

Shares of Wipro fell 0.07% to Rs 587.35 on BSE. Wipro is a global leader in information technology, consulting and business process services.

Powered by Capital Market – Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear reader,

Business Standard has always endeavored to provide up-to-date information and commentary on developments that matter to you and that have wider political and economic implications for the country and the world. Your constant encouragement and feedback on how to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these challenging times stemming from Covid-19, we remain committed to keeping you informed and updated with credible news, authoritative opinions and incisive commentary on relevant topical issues.
However, we have a request.

As we battle the economic impact of the pandemic, we need your support even more so that we can continue to bring you more great content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of bringing you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism we are committed to.

Support quality journalism and subscribe to Business Standard.

digital editor